AMPD3 (AMP deaminase 3) (P = 5.08 × 10 −9 and P = 4.33 × 10 −8 , respectively), and a novel 20:0-associated locus at CERS4 (ceramide synthase 4) (P = 1.76 × 10 −10 ). We also confirmed the previously reported association of FADS1/2-rs102275 with 18:0 (P = 1.12 × 10
Introduction
Dietary saturated fatty acids (SFAs) have long been considered independently as major risk factors for coronary heart disease (CHD) [1] . Moreover, plasma or erythrocyte SFAs, as surrogates of their intakes, have also been shown to be associated with risks of CHD [2, 3] , type 2 diabetes [4] , heart failure [5] , ischemic stroke [6] and Alzheimer's disease [7] . However, individual SFAs seem to have distinctive pathophysiological effects. For example, plasma phospholipid fatty acids 16:0 and 18:0 are associated with increased risk of CHD [3] , but no association between 14:0 and cardiovascular diseases is observed [3, 8] , and effects of long-chain SFAs, 20:0, 22:0 and 24:0, on type 2 diabetes and CHD remain to be known.
3
Circulating SFA concentrations are determined by dietary intake, absorption and endogenous synthesis. Therefore, genetic variants that alter uptake, absorption or synthesis of fatty acids may all contribute to the variation in blood SFA concentrations. So far, there is only one genome-wide association study (GWAS) in Europeanancestry populations that identified three novel loci that were associated with circulating concentrations of 16:0 and 18:0 [9] , and no studies have investigated the associations between genetic variants and circulating concentration of other SFAs, including 14:0 and long-chain SFAs. Moreover, compared with Europeans, East Asian populations have different dietary pattern and genetic background. A recent genetic adaptation analysis also demonstrated that the effect of fatty acid desaturase (FADS) haplotype on the efficiency of long-chain fatty acids synthesis ability differed between European and African descent, due to a shift in diet polyunsaturated fatty acids intake [10] . Therefore, it is of interest to investigate the transferability of reported genetic associations for de novo lipogenesis fatty acids to other ethnic populations. In the current analysis, we aimed to identify novel genetic variants for individual SFAs and to examine whether previously identified loci are also associated with circulating concentrations of 16:0 and 18:0 in East Asians from the Nutrition and Health of Aging Population in China (NHAPC) and the Multi-Ethnic Study of Atherosclerosis (MESA), two cohort studies from the Cohorts from Heart and Aging Research in Genomic Epidemiology (CHARGE) consortium.
Subjects and methods

Study cohorts
All data for this study were obtained from two cohort studies in the CHARGE consortium, the NHAPC and MESA study. The NHAPC study is a population-based cohort study among 3210 Chinese Hans, who aged 50-70 years during recruitments in Beijing and Shanghai. The study design, methods and measurements of this cohort study have been described in detail elsewhere [11] . Briefly, data on demographic variables, health status and physical activity were collected using a standardized questionnaire and anthropometric measurements, and overnight fasting blood samples were collected using a standardized protocol. Total cholesterol, LDL-c, HDL-c and triglyceride concentrations were measured enzymatically on an automatic analyzer (Hitachi 7080, Japan) with reagents purchased from Wako Pure Chemical Industries (Osaka, Japan). The MESA study is a study of the characteristics of subclinical cardiovascular disease and risk factors that predict progression to clinically overt cardiovascular disease or progression of the subclinical disease [12] . MESA study is a diverse, population-based sample of 6814 asymptomatic men and women aged 45-84 years, with about 12 % Asians, predominantly of Chinese descent. Written informed consent was obtained from all participants in both studies.
Fatty acid measurements
The total erythrocyte fatty acids were measured in NHAPC samples, while plasma phospholipid fatty acids were measured in the MESA samples. The method for erythrocyte fatty acid measurement in the NHAPC study has been previously described [13] . After being extracted by hexane and iso-propanol, erythrocyte fatty acids were incubated with a mixture of methanol and sulfuric acid for fatty acid methyl esters (FAMEs). FAMEs were then separated and identified by gas chromatography coupled with positive chemical ionization (Agilent 6890 GC-5975B) using methane as reagent gas. Fatty acids were obtained for a subset of 712 Chinese with genotypes available through MESA SHARe. Fatty acids of plasma, collected with EDTA and frozen at −70 °C, were measured using methods previously described by Cao et al. [14] . Lipids are extracted from the plasma using a chloroform/methanol extraction method, and cholesterol esters, triglycerides, phospholipids and free fatty acids are separated by thin-layer chromatography. The fatty acid methyl esters are obtained from the phospholipids and are detected by gas chromatography flame ionization. In both studies, relative amount of each fatty acid was calculated as the percentage of total fatty acids. Among the individual SFAs, 14:0, 16:0, 18:0, 20:0 and 22:0 were available in both cohorts and 24:0 was available only in the NHAPC study.
Genotyping and quality control
Details on genotyping and imputation for each cohort are provided in Supplemental Table 1 . Briefly, samples were genotyped using high-density single-nucleotide polymorphism (SNP) marker platforms, Illumina Human 660 W (Illumina, Inc., San Diego, California) in NHPAC and Affymetrix Genome-Wide Human SNP Array 6.0 in MESA (Santa Clara, California). Samples with call rate <97 % (NHAPC) or ≤95 % (MESA) were excluded. The samples in the NHAPC study that passed all QC criteria were then used to impute for the ungenotyped or missing SNPs from the HapMap phase II CHB + JPT (release #22-NCBI Build 36) reference panel, and samples in MESA SHARe Asian were imputed from the HapMap phase I and II CEU + YRI + CHB + JPT (release #22-NCBI Build 36) reference panel using IMPUTE software [15] . We removed all SNPs with MAF < 5 % (after meta-analysis), HWEP < 10
, or poor imputation quality, defined as the info measure ≤0.5 (NHAPC) or an observed divided by expected variance ≤0.8 (MESA).
Statistical analysis
Genome-wide association analysis for each individual fatty acid was conducted separately in NHAPC and MESA, and the summary statistics were then combined by inversevariance-weighted meta-analysis using METAL software (www.sph.umich.edu/csg/abecasis.metal).
In cohortspecific GWAS, linear regression analysis was applied to examine the association of each genotyped and imputed SNP with individual SFA level under an additive genetic model using ProbABEL (version 0.4.5) [16] . All analyses were adjusted for age, sex, site of recruitment and first two principal components, and used robust standard errors. P values were adjusted for genomic control inflation factor (λ GC ) [17] . Genomic control inflation factors in NHAPC and MESA were 1.043 and 1.017 for 14:0, 1.011 and 1.056 for 16:0, 1.013 and 1.013 for 18:0, 1.001 and 1.023 for 20:0, and 1.047 and 1.026 for 22:0, respectively, while inflation factor was 1.046 for 24:0 in NHAPC, suggesting minimal population stratification for each cohort. We then combined summary statistics of the associations from NHAPC and MESA cohorts using fixed-effect metaanalyses and tested for the heterogeneity between these two studies. P values for heterogeneity and I 2 were estimated. P values ≤ 5 × 10 −8 were considered significant. Generalized linear regression was applied to examine associations between SNPs with P ≤ 5 × 10 −8 and plasma lipid concentrations in NHAPC study, adjusting for age, sex, recruiting site and first two principal components under an additive genetic model using R software (version 2.15). All P values were two-sided, and P < 0.05 was considered to be statistically significant.
Results
The characteristics of two populations are shown in Table 1 As shown in Fig. 1 and Table 2 , multiple SNPs at LMX1A, AMPD3 and CERS4 loci reached genome-wide significance (P values <5 × 10 −8 ) for associations with SFA. Supplemental Tables 2-7 presented the associations of top SNPs (P < 5 × 10 −6 ) with each SFA in overall individuals, and Supplemental Table 8 presented the genomewide significant SNPs in cohort-specific GWASs.
Each copy of the minor T allele of SNP rs11589386, near LMX1A gene, was associated with 0.034 lower percentage of 14:0 (P = 5.08 × 10 −9 ) (Fig. 2a) . AMPD3 (at 11p15) is another locus (rs11042834 is the index SNP) that showed genome-wide significance for association with 14:0 (P = 4.33 × 10 −8
), and each copy of minor allele of this SNP was associated with 0.031 % decreased in 14:0 (Fig. 2b) .
Several SNPs at the CERS4 locus were associated with erythrocyte fatty acid 20:0 in the NHAPC study, and rs17159388 is the most significant SNP (P = 1.76 × 10 −10 , Table 2 ; Fig. 3) . Moreover, SNP rs651821 in APOA5 and rs168622 in SPTLC3 also showed suggestive evidence for association with erythrocyte fatty acid 20:0 (P ≤ 6.48 × 10 ) (Supplemental Table 5 ), whereas rs9349666 in ELOVL5 gene that involved in fatty acid metabolism showed suggestive evidence for association with fatty acid 24:0 (P = 3.88 × 10 ) in the NHAPC study (Supplemental Table 7 ).
For loci that have been previously reported to be associated with SFA (16:0 and 18:0), the association between 16:0 and ALG14-rs6675668 (P = 0.035), in high linkage disequilibrium with rs2391388 (r 2 = 0.90), was confirmed Table 9 ), and multiple SNPs in FADS1/2 also exhibited significant associations with 18:0 (i.e., P = 1.12 × 10 −5 for rs102275) ( Table 1 and Supplemental  Table 10 ) in this study.
We also examined the three novel genome-wide significant loci for associations with total cholesterol, low-density lipoprotein cholesterol (LDL-c), high-density lipoprotein cholesterol (HDL-c) and triglycerides in 2865 participants from NHAPC study (Supplemental Table 11 ). Minor alleles of AMPD3-rs11042834 and CERS4-rs17159388 were significantly associated with lower HDL-c concentrations (P = 0.0162 and 0.0161, respectively), after adjustment of age, gender, region and the first two principle components. Further controlling for 14:0 did not attenuate the effect of minor G allele of AMPD3-rs11042834 on HDL-c, while adjustment for 20:0 abolished the association between minor A allele of CERS4-rs17159388 and HDL-c.
Discussion
In this study of 3521 individuals of Chinese descent from two cohorts, three novel variants showed associations with blood SFA concentrations at genome-wide significance. Genetic variants in/or near AMPD3 and LMX1A genes were significantly associated with concentrations of 14:0, while genetic variants in CERS4 gene were significantly associated with concentrations of 20:0. AMPD3-rs11042834 and CERS4-rs17159388 were also nominally associated with plasma HDL-c concentration.
The strongest signal for association with 14:0 is rs11589386-C, which is near LMX1A gene (160 kb) encoding a homeodomain and LIM-domain containing protein [18] . LMX1A is widely expressed in pancreas, skeletal muscle, adipose tissue, kidney, brain and pituitary [19] . Previous studies have suggested that LIM-homeodomain protein Lmx1 acts as a positive regulator of insulin gene transcription by cooperating with the basic helix-loop-helix (bHLH) protein E47/Pan-1 [20] , and existing evidence also shown positive correlation between insulin sensitivity and 14:0 in cross-sectional studies [21, 22] . However, the mechanism underlying the association between LMX1-rs11589386 and 14:0 remains unknown.
Another genetic variant associated with 14:0 is rs11042834 in AMPD3 gene, which encodes erythrocyte adenosine monophosphate deaminase. The same variant is also associated with HDL-c, independent of erythrocyte 14:0 concentration. Consistent with our findings, a prior GWAS observed inverse association of rs2923084-A (not in linkage disequilibrium with rs11042834) near AMPD3 with HDL-c in populations of European origin (beta: −0.41 mg/ dL; equals to −0.0106 mmol/L) [23] . The protein AMPD3 is an erythrocyte-specific enzyme that catalyzes the hydrolytic deamination of adenosine monophosphate to inosine monophosphate, in the adenylate catabolic pathway [24] , and is widely expressed in tissues, including those of brain. Lanaspa et al. [25] reported that the activation of AMP deaminase led to increased production of uric acid and generation of mitochondrial oxidative stress, which further stimulated de novo lipogenesis and activated ATP-citrate lyase and long-chain saturated fatty acid syntheses. Further studies are needed to investigate whether genetic variation of AMP gene influence de novo synthesis of 14:0.
We found variants in CERS4 were associated with 20:0 concentrations at genome-wide significance concentration, with the most significant SNP being rs17159388. The saturated fatty acid 20:0 is an important component of sphingolipids. Our observation is consistent with prior GWAS in European participants which showed that several noncoding genetic variants in CERS4, although having non-linkage disequilibrium with rs17159388 (r 2 < 0.05), were associated with circulating plasma concentrations of sphingomyelins species 18:0, 18:1, 20:0, 20:1, ceramides 20:0 and ratios of sphingolipids [26, 27] . More recently, genetic variants in CERS4 associated with 20:0 were also reported in European populations [28] . The most significant SNP rs2100944 was not in LD with SNP rs17159388 identified in the current GWAS (r 2 = 0.012), and the P value of rs2100944 in Chinese populations was 0.040. CERS4 is expressed in most tissues including those of adipose and liver and involved in sphingolipid synthesis, especially longer chain ceramides [29] . The 20:0-increasing allele of CERS4-rs17159388 was also associated with higher HDL-c. But the association was abolished after further adjustment for 20:0, suggesting that the effect of CERS4 on HDL-c is likely to be mediated through an increased concentration of 20:0.
In cohort-specific GWAS, nine loci reached genomewide significance: six (FECHP, FAM110B, A1CF, JAM3, RASSF8 and MACROD2) for 14:0 and one (CERS4) for 20:0, in the NHAPC cohort, and one (LOC100128956) for 14:0 and one (ST8SIA5) for 22:0 in the MESA cohort (Supplemental Table 8 ). To avoid false-positive results from single GWAS, we conducted meta-analyses of GWAS study with larger sample size and only reported genome-wide significant SNPs in meta-analyses. SNPs at CERS4 remained significant after meta-analysis and were presented in Table 2 . Other SNPs showed suggestive significance after meta-analyses. Furthermore, we applied genomic control corrections in each study before meta-analysis to minimize potential confounding by population stratification [17] .
The current study highlights the strength of pooling GWAS data from different cohorts for identification of additional novel loci associated with SFA levels. Potential limitations should also be considered. Environmental factors, including dietary intake and lifestyles, may exert confounding effects on the SNP-SFA associations. However, we did not observe any heterogeneity between these two studied cohorts for the significant SNPs identified in the In conclusion, we identified three novel loci that were genome-wide significantly associated with saturated fatty acids, mainly with 14:0 and 20:0. These loci also affected Fig. 2 Regional plots of two novel loci for 14:0. Imputed SNPs were estimated by MACH software (see URLs) using LD information from 194 Asians (including 68 CHB, 25 CHS, 84 JPT and 17 MXL) in 1000 Genome 2010.08 release as references. P values were from meta-analysis adjusting for age, gender, region and the first two principle components. The regional plots for the 400-kb region centered on index SNPs were generated by using LocusZoom (see URLs).
The -log10P values of SNPs were plotted against their genomic position (NCBI Build 37). The positions of genes were annotated from the UCSC Genome Browser by using GRCh37 assembly. The Index SNPs are purple colored. Linkage disequilibrium (LD) is indicated by color scale in relationship to the Index SNPs, with red for strong LD (r 2 ≥ 0.8) and blue for lower LD Fig. 3 Regional plots of novel locus for 20:0. Imputed SNPs were estimated by MACH software (see URLs) using LD information from 194 Asians (including 68 CHB, 25 CHS, 84 JPT and 17 MXL) in 1000 Genome 2010.08 release as references. P values were from meta-analysis adjusting for age, gender, region and the first two principle components. The regional plots for the 400 kb region centered on index SNP was generated by using LocusZoom (see URLs). The -log10P values of SNPs were plotted against their genomic position (NCBI Build 37). The positions of genes were annotated from the UCSC Genome Browser by using GRCh37 assembly. The Index SNP is purple colored. Linkage disequilibrium (LD) is indicated by color scale in relationship to the Index SNP, with red for strong LD (r 2 ≥ 0.8) and blue for lower LD concentrations of HDL-c and LDL-c. Our findings expand our knowledge of genes involved in the determination of saturated fatty acids concentrations and provide new insights for future research.
